Kainos Med announces that their US Phase ... - Cure Parkinson's

Cure Parkinson's

25,727 members • 27,044 posts

Kainos Med announces that their US Phase 2 clinical trials for their FAF inhibitor KM-819

•0 Replies

Kainos Med announces that their US Phase 2 clinical trials for their FAF inhibitor KM-819 in #Parkinsons will begin in August; After optimal dose finding, 288 participants will be randomly assigned

koreabiomed.com/news/articl...

Read more about...

Not what you're looking for?

You may also like...

29% IMPROVEMENT in Alzheimer's using just 4 supplements in Phase 2 Clinical Study

PDWarrior1900 profile image
PDWarrior1900•
33 Replies

Hope bioscience is enrolling in 2 clinical trials

bio/amp/two-clinical-trials-85-billion-stem-cells-and-a-whole-lot-of-hope-in-the-fight-against-parki
7springshollow profile image
7springshollow•
18 Replies

Moderation team

See all
ParkinsonsEurope_Jen profile image
ParkinsonsEurope_JenAdministrator
CPT_Helen profile image
CPT_HelenPartner
GemmaMarks profile image
GemmaMarksPartner

Popular Posts

profile image
Afterlife
profile image
Extreme fatigue. Any solution?
profile image
walking getting bad..any solutions?
profile image
Nicotine…… a complete no-brainer.
profile image
Your best adjunct therapy pick

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.